MedTech Innovator

Samay specializes in remote respiratory health management. It develops AI-enabled wearable devices that monitor pulmonary volumes, trapped air, heart rates, breathing sounds, and lung temperature. This enables users to analyze their respiratory data and helps prevent respiratory diseases.

FibriCheck is a medically certified software-as-a-medical-device that detects irregular heart rhythms, including atrial fibrillation, through a smartphone camera. The app operates as a software-only solution on prescription, enabling users to measure cardiac rhythm anywhere and anytime, with data automatically shared with a medical professional to support faster diagnosis and appropriate treatment plans. The company leverages artificial intelligence to locate and track heart rhythm issues and to assist in managing conditions such as high blood pressure and heart failure, aiming to revolutionize cardiovascular care and empower patients to monitor and manage their heart health efficiently.

Invicta Medical develops innovative medical technologies for advanced sleep apnea treatments. Founded in 2013, the company is headquartered in Santa Clara, California.

SmartCardia SA is a Swiss company, established in 2013 and based in Lausanne, that specializes in the design and development of cardiac monitoring devices and cloud-based AI software. The company focuses on real-time patient monitoring by integrating advanced medical wearable technology with artificial intelligence. SmartCardia has created SmartNeuralNet, a cutting-edge machine learning technology that enhances their medical wearables. These ultra-small devices are designed to continuously track vital bio-signals, including heart rate, breathing rate, and skin conductance, allowing patients to monitor their health effectively. Through a dedicated mobile application, SmartCardia aims to provide actionable insights to individuals with chronic conditions, ultimately empowering them to improve their overall health management.

Samay specializes in remote respiratory health management. It develops AI-enabled wearable devices that monitor pulmonary volumes, trapped air, heart rates, breathing sounds, and lung temperature. This enables users to analyze their respiratory data and helps prevent respiratory diseases.

Founded in 2015, DiaMonTech specializes in developing non-invasive medical diagnostic devices. Its proprietary photo-thermal detection technology enables accurate glucose level measurements without finger pricking or blood samples.

Founded in 2015, Nanobiofab specializes in manufacturing smart, nanotech-based wearable healthcare devices for humans and pets. Its flagship product, iNose, detects and monitors skin vapor-print wirelessly via mobile phone, tracking fat burning rate, exercise effectiveness, and metabolic rate over time.

Neurava specializes in developing wearable diagnostic devices for epilepsy patients. Their products monitor health metrics, alert users and healthcare providers to seizures and cardiorespiratory dysfunctions, enabling timely intervention and improved treatment outcomes.

Proton Intelligence develops a wearable device that monitors potassium levels in real-time via interstitial fluid, closely correlated to blood. This enables clinicians and patients to manage medications and diets effectively for improved heart and kidney care, particularly targeting hyperkalemia in chronic kidney disease patients with co-morbidities.

CardieX is a global health technology company focused on cardiovascular health management, including hypertension and vascular disorders. It designs, manufactures, and markets medical devices and digital health tools that measure cardiovascular risk, monitor arterial stiffness and central blood pressure, and support patient management across hospitals, clinics, research institutions, and pharmaceutical companies in the Americas, Europe, and the Asia-Pacific region. The company offers TeleHealth services with digital, e-commerce, and mobile tools enabling online connections with health coaches. Its products include devices based on patented arterial stiffness and central blood pressure technologies, and wearables with health analytics. CardieX collaborates with external partners to develop wearable sensors and hypertension programs. The company traces its origins to AtCor Medical and rebranded to CardieX in 2018. CardieX was founded in 1994 and is headquartered in Sydney, Australia.

Flow Neuroscience, established in 2011 and based in Malmö, Sweden, specializes in developing and manufacturing a wearable device and accompanying mobile application for medication-free treatment of depression. The company's core product is a transcranial direct current stimulation (tDCS) headset that targets the left frontal lobe, an area of the brain often associated with depression. This non-invasive treatment is complemented by a personalized mobile app that encourages users to adopt healthier daily routines, such as regular exercise and sleep patterns, to help alleviate depressive symptoms. Flow Neuroscience aims to make this innovative, affordable treatment accessible to the public, challenging the dominance of pharmaceuticals in mental health care.

Senseye, Inc. is a Los Angeles-based company founded in 2015 that specializes in developing innovative smart contact lenses capable of non-invasively recording and analyzing information from users. These contact lenses are designed to infer human emotions, thoughts, and health states, thereby assisting in various applications such as market research, disease diagnosis, and early detection of medical conditions like strokes and heart attacks. By utilizing novel measurements of ocular physiology, Senseye aims to quantify cognitive abilities and psychological well-being, providing valuable insights into vital signs, attention, cognitive load, and fatigue. The company is committed to advancing technology that enhances emotional responses and mental health diagnostics, enabling clinicians to offer personalized care and effectively track patient outcomes over time.

Founded in 2017, JuneBrain develops wearable, non-invasive imaging devices for multiple sclerosis (MS) patients to monitor their disease activity at home. This enables early detection of MS attacks and improves treatment efficacy monitoring.

Neurava specializes in developing wearable diagnostic devices for epilepsy patients. Their products monitor health metrics, alert users and healthcare providers to seizures and cardiorespiratory dysfunctions, enabling timely intervention and improved treatment outcomes.

CARI Health develops wearable remote medication monitors that attach to the skin and continuously transmit data about medication levels to the cloud, enabling clinicians to prescribe medications and monitor real-time exposure. The sensor-enabled system supports personalized dosing by facilitating safe titration of therapies with narrow therapeutic windows, potentially improving dosing precision and patient outcomes. The company was founded in 2015 and is based in San Diego, California.

LiveMetric is a medical device company focused on developing innovative, non-invasive sensing and deep data analytics solutions aimed at improving the management of hypertension and cardiovascular diseases. The company offers a wearable, cuff-free device for blood pressure monitoring that is FDA-cleared and validated for accuracy against traditional arterial line methods. This technology provides high-fidelity arterial pressure waveforms and continuous tracking of vital signs, allowing for real-time feedback and analysis for patients, physicians, and healthcare providers. By delivering personalized data and detailed activity mapping, LiveMetric aims to empower individuals, payors, self-insured employers, and healthcare providers, ultimately enhancing the care and quality of life for over one billion people worldwide affected by these conditions.

MindMics is an emerging wearable company developing an in-ear, sound-based health monitoring platform that uses earbuds and hearing aids to measure biometrics in real time, including heartbeat, breathing, circadian rhythms, and body temperature, with the goal of supporting mental performance, focus, mindfulness, and overall well-being.

CardiaCare is a medical device company focused on neuromodulation therapy for atrial fibrillation. Its wearable device provides non-invasive treatment and at-home monitoring, utilizing a closed-loop system and machine learning to deliver personalized peripheral neuromodulation that aims to mediate a cardiovascular antiarrhythmic response, reduce the burden of atrial fibrillation and its precursors, and offer rapid clinical and symptomatic relief.

Augment Health is a company focused on developing noninvasive medical devices and artificial intelligence algorithms to enhance the management of bladder dysfunction, particularly for the 7 million patients affected by neurologic disease or injury. The company's innovative technology allows for monitoring urine levels through a device that can be attached to catheters, providing timely notifications to users or care providers when the catheter reaches capacity. This approach aims to shift bladder diagnostics from clinical settings to patients' homes, addressing the high rate of inconclusive test results associated with traditional in-clinic diagnostics. By enabling better bladder health management, Augment Health seeks to prevent complications such as bladder muscle atrophy, ultimately improving the quality of life for patients.

Flosonics Medical is a Canadian medical device company founded in 2017, specializing in the development of non-invasive sensors aimed at enhancing the management of critically ill patients. Its flagship product, the FloPatch, is a wearable ultrasound sensor designed to monitor blood flow in patients post-clinical intervention, thereby addressing critical clinical needs. The FloPatch is particularly beneficial for healthcare professionals, including physicians, nurses, and paramedics, operating in various high-pressure environments such as ambulances, emergency departments, operating rooms, and intensive care units. The device is notable for its portability, wireless connectivity with tablets and other medical equipment, and user-friendly functionality, all of which contribute to improved patient care in urgent medical situations. Flosonics Medical, previously known as Ke2 Technologies, rebranded in September 2017.

Sepsis Scout is a developer of a wearable patch designed to predict the onset of sepsis in high-risk patients in home care settings. Utilizing proprietary deep learning technology, the device aims to detect sepsis more accurately than current standards of care. By enabling patients to manage chronic illnesses effectively, Sepsis Scout's solution helps individuals stay out of the hospital and alleviates the fear and uncertainty associated with serious health conditions. The company's focus on artificial intelligence and wearables positions it at the forefront of innovative healthcare solutions.

Evergaze, Inc. is a company based in Richardson, Texas, that specializes in developing innovative visual aids for patients suffering from macular degeneration. Founded in 2016, the company has created a prescription eyewear device featuring a monocular electronic vision augmentation system, which is integrated into one lens to enhance visual capabilities. The founding team comprises highly experienced engineers with a proven track record in managing technical projects from conception to production. Drawing from their extensive backgrounds in commercial, industrial, and defense sectors, the team has focused on fulfilling a humanistic mission by leveraging their expertise to produce the seeBoost® device. This product is the result of comprehensive consultations with stakeholders in the low vision community, including patients, healthcare practitioners, and researchers, ensuring it meets the needs of its users effectively.

toSense, Inc. is a healthcare technology company based in San Diego, California, focused on developing innovative solutions for at-home monitoring of chronic illnesses. Incorporated in 2008 and previously known as Perminova, Inc., the company specializes in the CoVa Monitoring System, a body-worn sensor designed for patients with conditions such as congestive heart failure and chronic obstructive pulmonary disease. This device, resembling a necklace, measures vital signs including thoracic impedance, heart rate, and respiration rate, using disposable electrodes to ensure accurate monitoring. The collected data is transmitted via gateways to a web-based system, allowing healthcare professionals to review patient information and detect potential health issues earlier than traditional methods. toSense emphasizes the integration of its hardware and software solutions to address real-world medical challenges effectively. As of March 31, 2020, toSense operates as a subsidiary of Baxter International Inc.

Respirix, Inc. is a United States-based company focused on developing advanced analysis sensors for monitoring breath exhalation and cardiogenic oscillations. The company offers digital health software and hardware designed to provide proprietary insights into the pulmonary vasculature in a non-invasive manner. Respirix's product pipeline targets both at-home monitoring and critical care applications, specifically in areas such as heart failure and hemodynamics. Its innovative approach aims to enhance patient care by delivering precise and actionable data related to respiratory and cardiovascular health.

Koya Medical, Inc. is a healthcare company based in Oakland, California, founded in 2018. The company specializes in developing innovative wearable therapeutic devices aimed at treating cancer-related chronic lymphedema and various venous diseases. Koya Medical's technology offers active compression therapy that enhances mobility and personalized care, addressing limitations commonly associated with traditional compression methods. Its sensor-based closed-loop system provides patient-specific patterned compression, enabling healthcare providers to effectively manage conditions like chronic edema and chronic venous insufficiency. Through its breakthrough treatments, Koya Medical seeks to transform the standard of care for individuals affected by these debilitating conditions.

Spire Health, established in 2013 and headquartered in San Francisco, specializes in developing health-tracking devices and remote patient monitoring solutions. The company's core product is a wearable device that senses physical movement, position, and breathing patterns, providing insights into daily activities and mental state through a mobile application. Spire Health focuses on chronic respiratory disease management, offering solutions for conditions such as COPD, congestive heart failure, asthma, and sleep disorders. Their mission is to empower patients and physicians with useful, actionable data by harnessing the power of algorithms and sensors, thereby improving health outcomes.

Palmm develops a medical device offering at-home treatment for excessive sweating. Its wearable garment applies mild electrical currents to safely deactivate sweat glands on targeted areas like hands for up to several weeks, helping users regain confidence.

Nanowear, Inc. is a technology company specializing in textile-based nanosensor solutions for wireless and real-time electrophysiological monitoring. Founded in 2014 and headquartered in Brooklyn, New York, with a research and development facility in University Park, Pennsylvania, Nanowear develops innovative products such as SimplECG, a remote cardiac monitoring undergarment, and SimpleSense, designed for the management of congestive heart failure. These garments collect multi-channel electrocardiogram (ECG), heart rate, and respiratory rate data, transmitting it to a web-based portal accessible by healthcare professionals via a mobile application. The company's proprietary technology serves various markets, including cardiac, neurological, industrial safety, government, sports medicine, and performance diagnostics, providing accurate, continuous, and cost-effective diagnostic data in an unobtrusive manner.

Tueo Health is dedicated to improving asthma management, particularly for children. The company has developed an innovative solution that combines accurate, objective indicators of asthma control with clinical insights tailored to the needs of patients and their families. This system includes a contactless sensor designed to monitor and manage asthma effectively, allowing users to track treatment progress and outcomes. By focusing on these aspects, Tueo Health aims to enhance the quality of life for those living with asthma.

Spry Health, based in Palo Alto, California, develops digital health solutions aimed at improving care for chronically ill patients. The company offers a clinical-grade wearable device and a disease management platform that provides real-time analytics to healthcare payers. This technology helps manage patient conditions remotely, avoid preventable hospitalizations, and reduce overall healthcare spending by focusing on the small percentage of patients who account for a significant portion of health costs. Spry Health's solutions enhance timely care delivery through individualized analytics, ultimately improving patient outcomes and decreasing hospitalization rates. The company was incorporated in 2013.

MiNDERA Corporation specializes in the development of non-invasive molecular testing devices aimed at diagnosing skin cancer and other skin diseases. The company has created a micro-needle array patch that allows for pain-free and minimally invasive extraction of biomarkers, such as RNA, DNA, and proteins, from the skin without the need for traditional biopsies. Additionally, MiNDERA develops specialized patches for whole transcriptome extraction and skin microbiome extraction, which are designed for research applications. Founded in 2013, MiNDERA is headquartered in Palo Alto, California.

UnaliWear Inc. is a Texas-based company founded in 2013 that creates advanced wearable technology designed to enhance the independence and safety of seniors. Its flagship product, the Kanega watch, is often likened to an "OnStar for People," offering discreet support for falls, medication reminders, and guidance for those at risk of wandering. The watch features a user-friendly speech interface, eliminating the need for buttons, and incorporates a patented battery system, allowing continuous use without the necessity for recharging. Built with integrated cellular, Wi-Fi, GPS, and Bluetooth technologies, the Kanega watch provides round-the-clock medical alerts and utilizes artificial intelligence to learn and adapt to the wearer’s lifestyle. This innovative approach aims to empower vulnerable seniors by ensuring they receive timely assistance while maintaining their dignity and independence.

TinyKicks is a technology company headquartered in Irvine, California, founded in 2014 by France Helfer. The company specializes in developing a wireless smart sensor system that captures fetal movement using machine learning to promote healthy pregnancy outcomes. Its flagship product, the TinyKicks eMotion fetal activity monitor, is a wearable device that detects the user's baby kicks, distinguishing them from the mother's movements. This continuous monitoring provides real-time data, which is automatically uploaded to the user's smartphone. The system utilizes machine learning algorithms to identify abnormal fetal movement, enabling pregnant women to receive timely notifications about potential complications, thereby reducing costs associated with pregnancy-related issues and enhancing overall pregnancy health tracking.